Recent Analysts’ Ratings Changes for Omega Healthcare Investors (OHI)

by · The Markets Daily

Several analysts have recently updated their ratings and price targets for Omega Healthcare Investors (NYSE: OHI):

  • 10/22/2026 – Omega Healthcare Investors was upgraded by Citigroup from “buy” to “outperform”.
  • 10/22/2026 – Omega Healthcare Investors was upgraded by Citizens Jmp from “market perform” to “market outperform”. They now have a $52.00 price target on the stock.
  • 10/19/2026 – Omega Healthcare Investors had its price target lowered by Wells Fargo & Company from $48.00 to $46.00. They now have an “equal weight” rating on the stock.
  • 10/17/2026 – Omega Healthcare Investors was upgraded by Wall Street Zen from “hold” to “buy”.
  • 10/13/2026 – Omega Healthcare Investors had its price target lowered by Barclays from $50.00 to $48.00. They now have an “underweight” rating on the stock.
  • 10/13/2026 – Omega Healthcare Investors had its price target lowered by UBS Group from $54.00 to $52.00. They now have a “buy” rating on the stock.
  • 10/6/2026 – Omega Healthcare Investors had its “outperform” rating reaffirmed by Raymond James Financial. They now have a $53.00 price target on the stock.
  • 9/25/2026 – Omega Healthcare Investors had its “buy (b+)” rating reaffirmed by Weiss Ratings.

Omega Healthcare Investors Price Performance

Shares of NYSE:OHI traded up $1.65 during midday trading on Wednesday, hitting $49.18. The company had a trading volume of 3,148,047 shares, compared to its average volume of 2,077,554. Omega Healthcare Investors, Inc. has a twelve month low of $41.53 and a twelve month high of $52.39. The stock has a market cap of $14.90 billion, a price-to-earnings ratio of 17.56, a price-to-earnings-growth ratio of 1.90 and a beta of 0.56. The business’s 50-day simple moving average is $46.18 and its 200-day simple moving average is $46.63.

Omega Healthcare Investors (NYSE:OHI – Get Free Report) last released its quarterly earnings results on Tuesday, November 3rd. The real estate investment trust reported $0.27 EPS for the quarter, missing the consensus estimate of $0.47 by ($0.20). Omega Healthcare Investors had a net margin of 66.96% and a return on equity of 15.76%. The firm had revenue of $340.55 million for the quarter, compared to analysts’ expectations of $269.16 million. During the same period in the previous year, the firm posted $0.79 EPS. The firm’s quarterly revenue was down 3.0% compared to the same quarter last year. As a group, sell-side analysts forecast that Omega Healthcare Investors, Inc. will post 3.12 EPS for the current year.

Omega Healthcare Investors Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, November 16th. Shareholders of record on Thursday, November 5th will be paid a dividend of $0.68 per share. The ex-dividend date is Thursday, November 5th. This represents a $2.72 dividend on an annualized basis and a yield of 5.5%. Omega Healthcare Investors’s dividend payout ratio is 97.14%.

Omega Healthcare Investors, Inc is a real estate investment trust focused on the healthcare sector. The company invests in and owns healthcare facilities, with a primary emphasis on skilled nursing and assisted living properties.

Omega generally leases its properties to healthcare operators under long-term agreements, supporting services for seniors and individuals who require post-acute, rehabilitative, or long-term care. Its portfolio has also included other healthcare-related properties, such as continuing care retirement communities and specialty facilities.

Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega serves healthcare operators across the United States and the United Kingdom.

Read More